Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-033100
Filing Date
2022-11-21
Accepted
2022-11-21 16:07:27
Documents
71
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1120310
2 ex31-1.htm EX-31.1 13369
3 ex31-2.htm EX-31.2 13320
4 ex32-1.htm EX-32.1 7072
5 ex32-2.htm EX-32.2 6919
  Complete submission text file 0001493152-22-033100.txt   6365740

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ards-20220930.xsd EX-101.SCH 62120
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ards-20220930_cal.xml EX-101.CAL 57061
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ards-20220930_def.xml EX-101.DEF 250837
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ards-20220930_lab.xml EX-101.LAB 452022
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ards-20220930_pre.xml EX-101.PRE 358644
65 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 932134
Mailing Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032
Business Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032 (408) 385-1742
Aridis Pharmaceuticals, Inc. (Filer) CIK: 0001614067 (see all company filings)

IRS No.: 320074500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38630 | Film No.: 221405812
SIC: 2834 Pharmaceutical Preparations